Profile
Currently, Olaf Schermeier is CEO-Global Research & Development at Fresenius Medical Care AG & Co. KGaA and Chairman-Supervisory Board for Xenios AG (a subsidiary of Fresenius Medical Care AG & Co. KGaA). Dr. Schermeier is also on the board of Medos Medizintechnik AG and Member of Stifterverband für die Deutsche Wissenschaft eV, Member-Management Board at Fresenius Medical Care Management AG and Member-Administration Board at Unicyte AG. In the past Olaf Schermeier occupied the position of Manager-Strategic Product Planning at BIOTRONIK SE & Co. KG, Development Engineer at Robodent GmbH, President-Global Research & Development at Dräger Medical GmbH and Research Engineer at Charité - Universitätsmedizin Berlin. Dr. Schermeier received a doctorate from Technical University of Berlin and an undergraduate degree from the University of Hannover.
Olaf Schermeier active positions
| Companies | Position | Start |
|---|---|---|
Stifterverband für die Deutsche Wissenschaft eV | Corporate Officer/Principal | - |
Medos Medizintechnik AG
Medos Medizintechnik AG Medical SpecialtiesHealth Technology Manufactures medical devices | Director/Board Member | 01/01/2018 |
Unicyte AG
Unicyte AG Miscellaneous Commercial ServicesCommercial Services Operates as a transformative regenerative medicine company advancing stem cell technologies into a novel class of human therapeutics | Corporate Officer/Principal | - |
Former positions of Olaf Schermeier
| Companies | Position | End |
|---|---|---|
Fresenius Medical Care Management AG
Fresenius Medical Care Management AG Medical DistributorsDistribution Services Supplies dialysis products | Corporate Officer/Principal | 01/01/2022 |
Fiagon GmbH
Fiagon GmbH Medical SpecialtiesHealth Technology Provides medical navigation systems | Director/Board Member | 06/10/2016 |
Dräger Medical GmbH
Dräger Medical GmbH Medical SpecialtiesHealth Technology Manufactures and sells medical equipment and devices | Chief Tech/Sci/R&D Officer | 01/02/2013 |
BIOTRONIK SE & Co. KG
BIOTRONIK SE & Co. KG Medical SpecialtiesHealth Technology Manufactures stents and balloon catheters to treat blocked blood vessels | Corporate Officer/Principal | 01/01/2004 |
Robodent GmbH | Corporate Officer/Principal | 01/01/2002 |
Training of Olaf Schermeier
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Fresenius Medical Care AG
Fresenius Medical Care AG Medical/Nursing ServicesHealth Services Manufactures and supplies renal and dialysis products | Health Services |
BIOTRONIK SE & Co. KG
BIOTRONIK SE & Co. KG Medical SpecialtiesHealth Technology Manufactures stents and balloon catheters to treat blocked blood vessels | Health Technology |
University of Hannover
University of Hannover Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technical University of Berlin
Technical University of Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medos Medizintechnik AG
Medos Medizintechnik AG Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Charité - Universitätsmedizin Berlin
Charité - Universitätsmedizin Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fiagon GmbH
Fiagon GmbH Medical SpecialtiesHealth Technology Provides medical navigation systems | Health Technology |
Stifterverband für die Deutsche Wissenschaft eV | |
Fresenius Medical Care Management AG
Fresenius Medical Care Management AG Medical DistributorsDistribution Services Supplies dialysis products | Distribution Services |
Xenios AG
Xenios AG Medical SpecialtiesHealth Technology Develops and manufactures innovative devices for minimally invasive lung and heart support | Health Technology |
Dräger Medical GmbH
Dräger Medical GmbH Medical SpecialtiesHealth Technology Manufactures and sells medical equipment and devices | Health Technology |
Unicyte AG
Unicyte AG Miscellaneous Commercial ServicesCommercial Services Operates as a transformative regenerative medicine company advancing stem cell technologies into a novel class of human therapeutics | Commercial Services |
Robodent GmbH |
- Stock Market
- Insiders
- Olaf Schermeier
















